A retrospective, multicenter analysis of incidents associated with Axios (TM) lumen-apposing stents
Por:
Bazaga Pérez de Rozas S, Carbajo AY, Garcia-Alonso FJ, Martí D, Sánchiz Soler V, Martinez B, Aparicio J, Pedraza Sanz R, Vila Costas J, Vázquez-Sequeiros E, Villanueva Hernández R, Jordán Castro JA, Jiménez Palacios M, de la Serna Higuera C and Perez-Miranda Castillo M
Publicada:
1 ene 2019
Resumen:
Introduction: there is controversy with regard to the risks associated with lumen-apposing metal stents (LAMSs), with significant variations between available reports.
Objectives: to describe the types and proportions of complications that arise during the permanence time and removal of Axios (TM) LAMS. Furthermore, the relationship between patency time, therapeutic target and the presence of complications was also described.
Methods: a retrospective, multicenter case series study was performed of all patients with an implanted LAMS to access extra-luminal structures during 2017. Only technically successful cases were recorded.
Results: a total of 179 patients from seven sites (range, 4-68 cases/site) were included in the study, with a mean age of 64.3 years (SD: 15.8; range: 24.6-98.8 years) and 122 (68.2%) were male. Most common indications included encapsulated necrosis (58, 32.4%), pseudocysts (31, 17.3%) and gallbladder drains (26, 14.5%). Complications during LAMS stay were reported in 19 patients (10.9%); stent lumen or gastroduodenal obstruction (8, 4.5%) and bleeding (7, 3.9%) were the most common. LAMS were not removed in 86 (48%) patients due to the following reasons: a permanent stent was used (46, 53.5%), loss to follow-up (18, 20.9%), patient demise (16, 18.6%) and stent migration (6, 7%). Five (5.4%) complications were reported during stent removal, which were three bleeds and two perforations. No association was found between stent duration and complications (p = 0.67).
Conclusion: complications secondary to LAMS insertion are uncommon but may be serious. This study found no association between complications and stent duration.
Open Access
|